Eczema: all 1,088 studies

Page 9 of 11. Open to participants first (130), then studies with results posted, then the rest; newest registration first within each.

• Topical Solution for the Treatment of Atopic DermatitisCompletedNCT02865356Phase 2
• To Evaluate the in Use Tolerance of E45 Eczema Repair Emollient in Babies and Children With (Very(Dry/Atopic SkinCompletedNCT02857062Not applicable
• Antipruritic Effect of Acupuncture in Patients With Atopic DermatitisCompletedNCT02844452Not applicable
• The Effect of Gladskin on Disease Severity and the Skin Microbiome, Including Staphylococcus Aureus, in Patients With Atopic DermatitisCompletedNCT02840955Not applicable
• Texting Atopic Dermatitis Patients to Optimize Learning and EASI ScoresCompletedNCT02779426Not applicable
• Evaluating Results of Regularly Applied Emollient - Spray in Atopic Dermatitis TherapyStatus unknownNCT02763722Not applicable
• A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Adults With Atopic DermatitisCompletedNCT02757729Phase 2
• A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic DermatitisCompletedNCT02748993Phase 1/2
• Efficacy of the "Атопик Soothing Cream" in Children With Mild to Moderate Atopic DermatitisCompletedNCT02716181Not applicable
• Behavioral Self-Help Intervention for Pediatric Atopic Dermatitis and Eczema PatientsTerminatedNCT02713035Not applicable
• Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and OlderWithdrawnNCT02677636Phase 3
• Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and OlderWithdrawnNCT02677610Phase 3
• Indigo Naturalis in Treating Atopic Dermatitis TopicallyCompletedNCT02669888Phase 2
• Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)CompletedNCT02647086Phase 1
• A Multicenter Randomized Control Trial in Children With Moderate to Severe Atopic Dermatitis to Assess the Benefit of a Nurse-led One-to-one Education Program in Addition to Standard Care Compared to Standard Care Alone on the Long Term Control of Disease Severity at 6 MonthsTerminatedNCT02634905Not applicable
• A 47 Hour Occlusive Cutaneous Skin Patch Test on Adult Subjects With Dry/Atopic SkinCompletedNCT02620293Phase 1
• Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)Active, not recruitingNCT02612454Phase 3
• To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)CompletedNCT02601703Phase 3
• Efficacy and Safety of Runzao Zhiyang Capsule to Treat Chronic EczemaStatus unknownNCT02601222Phase 4
• The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic DermatitisCompletedNCT02594969Not applicable
• A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Atopic DermatitisCompletedNCT02583022Phase 2
• Atopy Patch Test in Children With Atopic DermatitisCompletedNCT02552979
• PRAgmatic Trial in Atopic Dermatitis Testing Long-term Control Effectiveness of New Phototherapy Regimen During Winter Coupled With Oral Vitamin D Supplementation vs. PlaceboCompletedNCT02537509Phase 2
• Intestinal Microbiota Composition After Antibiotic Treatment in Early LifeStatus unknownNCT02536560
• Ganoderma Tea on Eczema PatientStatus unknownNCT02533635Phase 1/2
• The Natural History of Atopic Disease in Thai Children and Association With Atopic MarchCompletedNCT02532920
• Trial on Effectiveness Combined Probiotics in Atopic Dermatitis in ChildrenCompletedNCT02519556Phase 4
• Xia Shi Surgical Treatment for Eczema Multi-center Clinical ResearchStatus unknownNCT02517957Phase 2
• An Explorative Trial Evaluating the Effect of LEO 32731 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)CompletedNCT02496546Phase 1
• Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic DermatitisCompletedNCT02475447Phase 2
• A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic DermatitisCompletedNCT02465606Phase 2
• Pharmacodynamics of Omiganan (CLS001) in Patients With Atopic DermatitisCompletedNCT02456480Phase 2
• Preventing Atopic Dermatitis and ALLergies in ChildrenActive, not recruitingNCT02449850Not applicable
• Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis PatientsCompletedNCT02426359Phase 2
• The Role of Filaggrin and FADS Genes on the Concentrations of PUFA Towards Its Effect on Atopic Dermatitis in InfantsCompletedNCT02401178
• A Study to Assess the Safety, Tolerability, PK and PD of AM1030-CREAM in Patients With Atopic DermatitisCompletedNCT02379910Phase 1/2
• DEC033 Study Product for Mild to Moderate Eczema An Open-label, Adaptive-design Pilot StudyCompletedNCT02379507Phase 1
• A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD)CompletedNCT02376049Phase 1
• Exploratory Study of the Cutaneous Penetration of Biodegradable Polymeric Microparticles in Atopic DermatitisTerminatedNCT02369432Early Phase 1
• A Single Ascending Dose Study in Healthy Participants and Multiple Ascending Dose Study of CNTO 7160 in Participants With Asthma and Participants With Atopic DermatitisCompletedNCT02345928Phase 1
• A Study to Evaluate Use of Induced Skin Blisters in Adult Participants With Atopic Dermatitis, Allergic Asthma and Atopic Healthy ParticipantsCompletedNCT02343783Early Phase 1
• A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic DermatitisCompletedNCT02340234Phase 2
• Cognitive Behavior Therapy for Atopic DermatitisCompletedNCT02302625Not applicable
• Role of Anti-IgE in Severe Childhood EczemaCompletedNCT02300701Phase 4
• Skin Effects of a Topical Amino Acid Moisturizing Cream and Desonide in Atopic DermatitisStatus unknownNCT02286700Phase 3
• Treatment of Chronic Itch in Atopic Dermatitis (Eczema): Nerve FunctionCompletedNCT02268448Phase 1
• Randomized Controlled Trial of an Eczema Care PlanCompletedNCT02251340Not applicable
• 0.005% Sodium Hypochlorite Final Rinse Solution in Atopic DermatitisWithdrawnNCT02241174Phase 1
• Photophoresis Versus Ciclosporine in Severe Atopic DermatitisCompletedNCT02226068Not applicable
• Study to Examine the Benefits of Fabric Made With Lyocell/Chitosan/Ceramide in the Treatment of Children With Mild to Moderate EczemaWithdrawnNCT02224950Not applicable
• Effect of LEO 39652 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)CompletedNCT02219633Phase 1
• Haut-Tief Patient Education on Psoriasis and EczemaStatus unknownNCT02205593Not applicable
• Taking Into Account the Patient/Parent Preference in the Galenic Choice in Atopic Dermatitis. Feasibility and Impact on Treatment AdherenceCompletedNCT02193230
• Effect of Holly Mangrove Shower Gel in Atopic Dermatitis PatientsCompletedNCT02178215Phase 3
• Study to Determine the Pharmacokinetics of Product 0405WithdrawnNCT02176577Phase 3
• Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric SubjectsWithdrawnNCT02176538Phase 3
• Atopic Dermatitis Adherence StudyStatus unknownNCT02169986Not applicable
• Treatment of Atopic Dermatitis With Different Orders of Application of Locoid Lotion and Hylatopic Plus CreamCompletedNCT02153762Not applicable
• Safety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic DermatitisCompletedNCT02148744Phase 1
• Evaluation of the Kinetic Properties of an Autologous Microbiome Transplant in Adult Atopic Dermatitis PatientsWithdrawnNCT02144142Phase 2
• Pilot Tape Harvesting StudyCompletedNCT02125695
• Can Vitamin D Supplementation in the First Year of Life Prevent Food Allergy in Infants? The VITALITY Trial: Parts 1&2Active, not recruitingNCT02112734Phase 4
• Assessment of Efficacy of the Consumption of a Heat-treated Lactobacillus Paracasei (GM080) on Atopic DermatitisCompletedNCT02103972Not applicable
• A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic DermatitisCompletedNCT02103725Phase 1
• Skin Testing With Recombinant Bet v 1 and Hypoallergenic Recombinant Bet v 1 FragmentsCompletedNCT02098551
• Placebo Effect in the Treatment of Atopic DermatitisCompletedNCT02094287Not applicable
• A Phase 1/2 Study of E6005 in Pediatric Subjects With Atopic DermatitisCompletedNCT02094235Phase 1/2
• S. Aureus Colonization in Atopic DermatitisCompletedNCT02091037
• Accessible and Affordable Moisturizers for Atopic EczemaCompletedNCT02084472Not applicable
• Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 Applied to Lesional Skin in Patients With Atopic EczemaCompletedNCT02079688Phase 2
• Correlation Study Between PEST and SCORAD in Management of Atopic Dermatitis With Ceradan® RegimenCompletedNCT02073591
• A Psychoeducational Prevention for the Treatment of Atopic Dermatitis in Youth and Their FamiliesWithdrawnNCT02067234Not applicable
• Effect of Oral Vitamin D Supplement on Atopic Dermatitis; A Clinical Trial With Staphylococcus Aureus Colonization DeterminationCompletedNCT02058186Not applicable
• Double-Blind, Trial to Evaluate the Safety and Efficacy of MRX-6 Cream 2%TerminatedNCT02031445Phase 2
• The Effect of Bathing and Moisturizers on Skin Hydration in Atopic Dermatitis: an in Vivo StudyCompletedNCT02028546Not applicable
• Phase 2 Study of KHK4577CompletedNCT02004119Phase 2
• Impact of Vitamin D Supplementation on Severity of Pediatric Atopic DermatitisCompletedNCT01996423Not applicable
• Bleach Bath Treatment of Adults With Atopic DermatitisCompletedNCT01996150Not applicable
• The Effect of Anti-CεmX on IgE ProductionCompletedNCT01995747
• A Safety and Efficacy of DRM02 in Subjects With Atopic DermatitisCompletedNCT01993420Phase 2
• Examination of Whether Host Preconditioning Modifies Short-term Transplant SurvivalWithdrawnNCT01960764Phase 1
• Efficacy/Safety Study to Explore a New Revised Topical Formulation in Atopic DermatitisCompletedNCT01948869Not applicable
• The Effects of Polyunsaturated Fatty Acids (PUFA) on Allergic/Atopic DermatitisWithdrawnNCT01936194Not applicable
• At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
• Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis (AD)CompletedNCT01927705Phase 1/2
• Efficacy Study of Dialyzed Leukocytes Extracts to Treat Paediatric Moderate Atopic DermatitisCompletedNCT01902836Phase 2
• A Randomised Clinical Trial on the Effect of Group Education on Patients With Occupational Hand EczemaCompletedNCT01899287Not applicable
• A Study to Assess CLn® BodyWash for Reducing Skin Fauna in Patients With Hand EczemaTerminatedNCT01826630Not applicable
• An Evaluation of PDI-192 0.1% in Comparison to PDI-192 0.15% in the Treatment of Mild to Moderate Atopic DermatitisCompletedNCT01826461Phase 2
• A Study to Evaluate the Efficacy, Safety and Tolerability of CT327 in Atopic DermatitisCompletedNCT01808157Phase 2
• PF and FeNO and Clinical Characteristics in Children Being Diagnosed Due to Suspicion of Allergic DiseasesStatus unknownNCT01805635
• Sertaconazole 2% Cream to Improve Symptoms Associated With Atopic DermatitisCompletedNCT01792713Phase 2
• Extended Release Tacrolimus (Advagraf®) in Severe Adult Atopic Dermatitis PatientsCompletedNCT01789619
• Defining the Skin and Blood Biomarkers of Pediatric Atopic DermatitisActive, not recruitingNCT01782703
• Efficacy of KAM2904 Face Cream and KAM3008 Body Lotion Treatment in Children With Atopic Dermatitis (AD)Status unknownNCT01781663Phase 4
• Emollients in the Management of Atopic DermatitisCompletedNCT01779258Phase 3
• Preventive Treatment of Tacrolimus Ointment in Children With Atopic DermatitisCompletedNCT01745159Phase 4
• A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema PatientsCompletedNCT01714245
• A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic DermatitisCompletedNCT01702181Phase 1
• Assessing the Impact of Pioglitazone on Skin Barrier Function in Atopic Dermatitis PatientsWithdrawnNCT01695707Not applicable

← Eczema overview